290 related articles for article (PubMed ID: 17048521)
1. Poly(lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanoparticles: drug loading and release properties.
Katsikogianni G; Avgoustakis K
J Nanosci Nanotechnol; 2006; 6(9-10):3080-6. PubMed ID: 17048521
[TBL] [Abstract][Full Text] [Related]
2. Adriamycin release from poly(lactide-coglycolide)-polyethylene glycol nanoparticles: synthesis, and in vitro characterization.
Davaran S; Rashidi MR; Pourabbas B; Dadashzadeh M; Haghshenas NM
Int J Nanomedicine; 2006; 1(4):535-9. PubMed ID: 17722284
[TBL] [Abstract][Full Text] [Related]
3. Sustained release of bovine serum albumin using implantable wafers prepared by MPEG-PLGA diblock copolymers.
Kim MS; Seo KS; Hyun H; Kim SK; Khang G; Lee HB
Int J Pharm; 2005 Nov; 304(1-2):165-77. PubMed ID: 16198075
[TBL] [Abstract][Full Text] [Related]
4. Effect of conditions of preparation on the size and encapsulation properties of PLGA-mPEG nanoparticles of cisplatin.
Gryparis EC; Mattheolabakis G; Bikiaris D; Avgoustakis K
Drug Deliv; 2007 Aug; 14(6):371-80. PubMed ID: 17701526
[TBL] [Abstract][Full Text] [Related]
5. Preparation of DHAQ-loaded mPEG-PLGA-mPEG nanoparticles and evaluation of drug release behaviors in vitro/in vivo.
Duan Y; Sun X; Gong T; Wang Q; Zhang Z
J Mater Sci Mater Med; 2006 Jun; 17(6):509-16. PubMed ID: 16691348
[TBL] [Abstract][Full Text] [Related]
6. Novel thermosensitive nano-micelles from triblock copolymer for drug delivery.
Liu P; Wang B; Qiao W; Li J
J Biomed Nanotechnol; 2009 Jun; 5(3):310-3. PubMed ID: 20055013
[TBL] [Abstract][Full Text] [Related]
7. Design and Development of Bioceramic Based Functionalized PLGA Nanoparticles of Risedronate for Bone Targeting: In-vitro Characterization and Pharmacodynamic Evaluation.
Rawat P; Manglani K; Gupta S; Kalam A; Vohora D; Ahmad FJ; Talegaonkar S
Pharm Res; 2015 Oct; 32(10):3149-58. PubMed ID: 25840949
[TBL] [Abstract][Full Text] [Related]
8. PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties.
Avgoustakis K; Beletsi A; Panagi Z; Klepetsanis P; Karydas AG; Ithakissios DS
J Control Release; 2002 Feb; 79(1-3):123-35. PubMed ID: 11853924
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
10. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
11. Effect of preparation conditions on the size and encapsulation properties of mPEG-PLGA nanoparticles simultaneously loaded with vincristine sulfate and curcumin.
Wang H; Jia Y; Hu W; Jiang H; Zhang J; Zhang L
Pharm Dev Technol; 2013; 18(3):694-700. PubMed ID: 22676257
[TBL] [Abstract][Full Text] [Related]
12. Formulation and evaluation of biodegradable nanoparticles for the oral delivery of fenretinide.
Graves RA; Ledet GA; Glotser EY; Mitchner DM; Bostanian LA; Mandal TK
Eur J Pharm Sci; 2015 Aug; 76():1-9. PubMed ID: 25933716
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation.
Yang A; Yang L; Liu W; Li Z; Xu H; Yang X
Int J Pharm; 2007 Feb; 331(1):123-32. PubMed ID: 17097246
[TBL] [Abstract][Full Text] [Related]
14. Idarubicin-loaded methoxy poly(ethylene glycol)-
Liang B; Li N; Zhang S; Qi A; Feng J; Jing W; Shi C; Ma Z; Gao S
Int J Nanomedicine; 2019; 14():543-556. PubMed ID: 30666113
[TBL] [Abstract][Full Text] [Related]
15. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
Packhaeuser CB; Kissel T
J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles of poly(D,L-lactide)/methoxy poly(ethylene glycol)-poly(D,L-lactide) blends for controlled release of paclitaxel.
Dong Y; Feng SS
J Biomed Mater Res A; 2006 Jul; 78(1):12-9. PubMed ID: 16596586
[TBL] [Abstract][Full Text] [Related]
17. Stable loading and delivery of disulfiram with mPEG-PLGA/PCL mixed nanoparticles for tumor therapy.
Song W; Tang Z; Lei T; Wen X; Wang G; Zhang D; Deng M; Tang X; Chen X
Nanomedicine; 2016 Feb; 12(2):377-86. PubMed ID: 26711966
[TBL] [Abstract][Full Text] [Related]
18. [Preparation of cyclosporine A loaded mPEG-PLGA copolymer micelles and study its pharmacokinetics in rats].
Yao DG; Sun KX; Mu HJ; Zhou FM; Chen HH; Liu LJ; Liang N
Yao Xue Xue Bao; 2009 Dec; 44(12):1410-5. PubMed ID: 21351479
[TBL] [Abstract][Full Text] [Related]
19. The effects of mPEG proportion and LA/GA ratio on degradation and drug release behaviors of PLGA-mPEG microparticles.
Shi C; Liu P; Liu X; Feng X; Fu D
Pharmazie; 2016 May; 71(5):243-6. PubMed ID: 27348966
[TBL] [Abstract][Full Text] [Related]
20. The influence of mPEG-PCL and mPEG-PLGA on encapsulation efficiency and drug-loading of SN-38 NPs.
Gan M; Zhang W; Wei S; Dang H
Artif Cells Nanomed Biotechnol; 2017 Mar; 45(2):389-397. PubMed ID: 27043776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
